
September 10, 2024
RegMed Investors (RMi) Research Note: Ionis Pharmaceuticals (IONS) prices a $500.3 M public offering
September 10, 2024
RegMed Investors’ (RMi) pre-open: maintaining an upside pricing or?
September 9, 2024
RegMed Investors (RMi) Closing Bell: rebound after multiple hard falls
September 9, 2024
RegMed Investors’ (RMi) pre-open: a sea of red last week
September 6, 2024
RegMed Investors (RMi) Closing Bell: cell and gene therapy equities lost altitude
September 6, 2024
RegMed Investors’ (RMi) pre-open: twisting and turning
September 5, 2024
RegMed Investors (RMi) Closing Bell: risks are riskier skewed to the downside
September 5, 2024
RegMed Investors’ (RMi) pre-open: creeping upside as weekly jobless claims data focuses the session
September 4, 2024
RegMed Investors (RMi) Closing Bell: Brewin’ for screwin’ with more than a few low-conviction trades
September 4, 2024
RegMed Investors’ (RMi) pre-open: Will market Sirens continue to lure sector investors to rocky shores
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors